NCT03972371 - The ProVerum First in Man PROVE Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

December 1, 2021

Study Completion Date

November 27, 2023

Conditions

Benign Prostatic Hyperplasia

Interventions

DEVICE

The ProVee Urethral Expander System

The ProVee Urethral Expander System is supplied as a single use, sterile device and consists of a nitinol expander implant and custom implant delivery system. The delivery system is designed to allow the implant to be deployed under direct vision.

Trial Locations (1)

Unknown

The Royal Melbourne Hospital, Melbourne